[
    [
        {
            "time": "",
            "original_text": "干货！2021年中国疫苗行业龙头企业分析——康希诺：商业化程度低、未来难阻巨亏 重大损失",
            "features": {
                "keywords": [
                    "疫苗",
                    "康希诺",
                    "商业化程度低",
                    "巨亏",
                    "重大损失"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "疫苗"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "干货！2021年中国疫苗行业龙头企业分析——康希诺：商业化程度低、未来难阻巨亏 重大损失",
                "Correlation": 9,
                "Sentiment": 2,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 5,
                "Headline_Structure": 9,
                "Source_Recency": 5
            }
        }
    ]
]